The patent EP4603591 was granted to Novozymes on Aug 20, 2025. The application was originally filed on Aug 30, 2018. The patent is currently recorded with a legal status of "Pending".

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.
Get instant alerts for new documents